Vinpocetine Injection

Category: Cerebral vasodilator / Nootropic agent
Form: Injectable solution (intravenous or intramuscular)

Uses:

• Improves cerebral blood flow in conditions such as stroke, cerebrovascular disorders, and transient ischemic attacks (TIA).

• Sometimes used for memory disorders, cognitive decline, or dementia, though its efficacy varies.

• May help in improving oxygen and glucose utilization in brain tissues.

Mechanism of Action:

• Vinpocetine selectively dilates cerebral blood vessels, increasing blood flow to the brain.

• Enhances oxygen and glucose uptake by neurons.

• Inhibits phosphodiesterase type 1 (PDE1) and reduces platelet aggregation, which may improve microcirculation.

• Exhibits neuroprotective properties by reducing neuronal damage caused by ischemia.

Administration:

• Administered intravenously over 5–10 minutes or intramuscularly, depending on the clinical setting.

• Dosage depends on patient condition, age, and severity of cerebral ischemia.

Side Effects:

• Generally well tolerated.

• Mild headache, dizziness, flushing, or nausea may occur.

• Rare: hypotension, allergic reactions, or tachycardia.

Precautions:

• Use caution in patients with low blood pressure.

• Avoid in individuals with allergy to vinca alkaloids or excipients.

• Monitor for neurological changes during therapy.

Summary:
Vinpocetine Injection is used to enhance cerebral blood flow and oxygen delivery, mainly in patients with stroke, cerebrovascular disorders, or cognitive impairment. It works by dilating cerebral vessels, improving oxygen and glucose utilization, and providing neuroprotective effects. Administered intravenously or intramuscularly, it is generally well tolerated, with mild headache, dizziness, or nausea being the most common side effects.